Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application



      The model of chronic dermatitis caused by repeated application of hapten is frequently used as a tool for assessment of the efficacy of a compound or the elucidation of chronic dermatitis.


      The purpose of this study is to provide more detailed analysis of the model of chronic dermatitis caused by repeated application of 2,4,6-trinitro-1-chlorobenzene (TNCB).


      BALB/c mice were sensitized with TNCB on day −7 to the ear, and then TNCB was repeatedly applied to the same ear three times per week, through days 0–21.


      The repeated application of TNCB induced an increase of ear thickness, and a relatively steep increment of ear thickness from days 7 to 9 was observed. This increment reached almost a plateau at day 9. The peaks of ear swelling on days 7, 14 and 21 were approximately two times higher than that on day 0. Regarding cytokines in the ear, the highest production of IL-1β, 4, 6 and 18 were observed on day 7. The peak production of IL-1β, 4 and 6 on day 7 was found within 24 h after the challenge, while that of IL-18 was found at 0 h. The inflammatory cell infiltration into epidermis and dermis was observed and increased in day 7, then reached almost a plateau on day 9.


      The indices such as thickness, swelling and inflammatory cell infiltration in the lesional skin was increased and maintained by repeated application, however, the protein levels of some cytokines were not always consistent with the reactions.


      To read this article in full you will need to make a payment


        • Kitagaki H.
        • Fujisawa S.
        • Watanabe K.
        • Hayakawa K.
        • Shiohara T.
        Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice.
        J Invest Dermatol. 1995; 105: 749-755
        • Kitagaki H.
        • Ono N.
        • Hayakawa K.
        • Kitazawa T.
        • Watanabe K.
        • Shiohara T.
        Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile.
        J Immunol. 1997; 159: 2484-2491
        • Kitagaki H.
        • Kimishima M.
        • Teraki Y.
        • Hayakawa J.
        • Hayakawa K.
        • Fujisawa S.
        • et al.
        Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase.
        J Immunol. 1999; 163: 1265-1273
        • Inoue Y.
        • Isobe M.
        • Shiohara T.
        • Goto Y.
        • Hayashi H.
        Protective and curative effects of topically applied CX-659S, a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses.
        Br J Dermatol. 2002; 147: 675-682
        • Griswold D.E.
        • Webb E.F.
        • Badger A.M.
        • Gorycki P.D.
        • Levandoski P.A.
        • Barnette M.A.
        • et al.
        SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
        J Pharmacol Exp Ther. 1998; 287: 705-711
        • Fujii Y.
        • Takeuchi H.
        • Tanaka K.
        • Sakuma S.
        • Ohkubo Y.
        • Mutoh S.
        Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats.
        Eur J Pharmacol. 2002; 456: 115-121
        • Nakada T.
        • Watanabe K.
        • Matsumoto T.
        • Santa K.
        • Triizuka K.
        • Hanawa T.
        Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen.
        Int Immunopharmacol. 2002; 2: 901-911
        • Shimada Y.
        • Hasegawa M.
        • Kaburagi Y.
        • Hamaguchi Y.
        • Komura K.
        • Saito E.
        • et al.
        l-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity.
        J Immunol. 2003; 170: 4325-4334
        • Kawase Y.
        • Hoshino T.
        • Yokota K.
        • Kuzuhara A.
        • Kirii Y.
        • Nishiwaki E.
        • et al.
        Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin.
        J Invest Dermatol. 2003; 121: 502-509
        • Webb E.F.
        • Tzimas M.N.
        • Newsholme S.J.
        • Griswold D.E.
        Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4.
        J Invest Dermatol. 1998; 111: 86-92
        • Dieli F.
        • Sireci G.
        • Scire E.
        • Salerno A.
        • Bellavia A.
        Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice.
        Immunology. 1999; 98: 71-79
        • Elbe-Burger A.
        • Egyed A.
        • Olt S.
        • Klubal R.
        • Mann U.
        • Rappersberger K.
        • et al.
        Overexpression of IL-4 alters the homeostasis in the skin.
        J Invest Dermatol. 2002; 118: 767-778
        • Enk A.H.
        • Katz S.I.
        Early molecular events in the induction phase of contact sensitivity.
        Proc Natl Acad Sci USA. 1992; 89: 1398-1402
        • Enk A.H.
        • Angeloni V.L.
        • Udey M.C.
        • Katz S.I.
        An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin.
        J Immunol. 1993; 150: 3698-3704
        • Shornick L.P.
        • De Togni P.
        • Mariathasan S.
        • Goellner J.
        • Strauss-Schoenberger J.
        • Karr R.W.
        • et al.
        Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.
        J Exp Med. 1996; 183: 1427-1436
        • Sato M.
        • Sawamura D.
        • Ina S.
        • Yaguchi T.
        • Hanada K.
        • Hashimoto I.
        In vivo introduction of the interleukin 6 gene into human keratinocytes: induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form.
        Arch Dermatol Res. 1999; 291: 400-404
        • Saitoh A.
        • Yasaka N.
        • Osada A.
        • Nakamura K.
        • Furue M.
        • Tamaki K.
        Migration of Langerhans cells in an in vitro organ culture system: IL-6 and TNF-alpha are partially responsible for migration into the epidermis.
        J Dermatol Sci. 1999; 19: 166-174
        • Schoeler D.
        • Grutzkau A.
        • Henz B.M.
        • Kuchler J.
        • Kruger-Krasagakis S.
        Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins.
        J Invest Dermatol. 2003; 120: 795-801
        • Cowden W.B.
        • Cullen F.A.
        • Staykova M.A.
        • Willenborg D.O.
        Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.
        J Neuroimmunol. 1998; 88: 1-8
        • Xiong H.
        • Zhu C.
        • Li F.
        • Hegazi R.
        • He K.
        • Babyatsky M.
        • et al.
        Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells.
        J Biol Chem. 2004; 279: 10776-10783
        • Borish L.
        IL-10: evolving concepts.
        J Allergy Clin Immunol. 1998; 101: 293-297
        • Del Prete G.
        • De Carli M.
        • Almerigogna F.
        • Giudizi M.G.
        • Biagiotti R.
        • Romagnani S.
        Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.
        J Immunol. 1993; 150: 353-360
        • Okamura H.
        • Tsutsi H.
        • Komatsu T.
        • Yutsudo M.
        • Hakura A.
        • Tanimoto T.
        Cloning of a new cytokine that induces IFN-gamma production by T cells.
        Nature. 1995; 378: 88-91
        • Okamura H.
        • Tsutsui H.
        • Kashiwamura S.
        • Yoshimoto T.
        • Nakanishi K.
        Interleukin-18: a novel cytokine that augments both innate and acquired immunity.
        Adv Immunol. 1998; 70: 281-312
        • Dinarello C.A.
        IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.
        J Allergy Clin Immunol. 1999; 103: 11-24
        • Yoshimoto T.
        • Tsutsui H.
        • Tominaga K.
        • Hoshino K.
        • Okamura H.
        • Akira S.
        • et al.
        IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.
        Proc Natl Acad Sci USA. 1999; 96: 13962-13966
        • Hoshino T.
        • Wiltrout R.H.
        • Young H.A.
        IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.
        J Immunol. 1999; 162: 5070-5077
        • Yoshimoto T.
        • Mizutani H.
        • Tsutsui H.
        • Noben-Trauth N.
        • Yamanaka K.
        • Tanaka M.
        • et al.
        IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6.
        Nat Immunol. 2000; 1: 132-137
        • Kawase Y.
        • Hoshino T.
        • Yokota K.
        • Kuzuhara A.
        • Kirii Y.
        • Nishiwaki E.
        • et al.
        Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin.
        J Invest Dermatol. 2003; 121: 502-509
        • Novick D.
        • Kim S.H.
        • Fantuzzi G.
        • Reznikov L.L.
        • Dinarello C.A.
        • Rubinstein M.
        Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.
        Immunity. 1999; 10: 127-136
        • Hoshino T.
        • Kawase Y.
        • Okamoto M.
        • Yokota K.
        • Yoshino K.
        • Yamamura K.
        • et al.
        IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function.
        J Immunol. 2001; 166: 7014-7018
        • Nakano H.
        • Tsutsui H.
        • Terada M.
        • Yasuda K.
        • Matsui K.
        • Yumikura-Futatsugi S.
        • et al.
        Persistent secretion of IL-18 in the skin contributes to IgE response in mice.
        Int Immunol. 2003; 15: 611-621